Home » Special Interest Groups » PSU

Perinatal Substance Use - PSU

The Perinatal Substance Use SIG has been established to maintain liason with international bodies, advance members' knowledge in managing perinatal substance use, promote research and data collection in the field and provide advice on matters pertaining PSU.

The goal of this national special interest group is to establish and maintain a forum of stakeholders in perinatal substance use, with activities which:

• Maintain liaison with international bodies in perinatal substance use through the promotion of this interest forum.
  
• Examine the feasibility of establishing clinical indicators and /or national database for benchmarking purposes
• Advance members’ knowledge and skills in managing perinatal substance use
• Examine the feasibility of establishing clinical indicators and /or national database for benchmarking purposes
• Promote research and data collection in perinatal substance use
• Explore best practice models of care for perinatal substance use and neonatal abstinence syndrome that are sensitive and flexible to regional, cultural and community differences
• Provide expert advice to government and other bodies on matters pertaining to perinatal substance use

Newsletters

• April 2003
• July 2003
• November 2003
• June 2004
• November 2006
• September 2007
  

National Clinical Guidelines

'National clinical guidelines for the management of drug use during pregnancy, birth and the early development years of the newborn Commissioned by the Ministerial Council on Drug Strategy under the Cost Shared Funding Model, 2006'
Download (2 MB)

Contact Details

Acting Secretariat

• Ann Kingsbury

Executive Committee

• Professor David Tudehope
  Neonatologist
  Mater Mothers' Hospital
  Queensland
• Dr Kei Lui
  Neonatologist
  Sydney Children's Hospital
  New South Wales
• Professor Anne Bartu
  Drug & Alcohol Office
  Western Australia
• Dr Jill Mckie
  Staff Specialist- Neonatology
  Christchurch Women's Hospital